Benztropine Mesylate
NDC 50228-226, Benztropine Mesylate, tablet, from ScieGen Pharmaceuticals Inc.
- Product NDC
- 50228-226
- Status
- Listed
- Labeler
- ScieGen Pharmaceuticals Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040103
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50228-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENZTROPINE MESYLATE1 mg/1
Pharmacologic classes
Anticholinergic [EPC]; Antihistamine [EPC]; Cholinergic Antagonists [MoA]; Histamine Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50228-226-01 | 50228022601 | 100 TABLET in 1 BOTTLE (50228-226-01) |
| 50228-226-10 | 50228022610 | 1000 TABLET in 1 BOTTLE (50228-226-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1ead16a7-88ed-407d-b25a-0d9a1d9da5efNADAC price for package 50228022601
GET /v1/drugs/nadac/50228022601NADAC price for package 50228022610
GET /v1/drugs/nadac/50228022610
Use it
Look up 50228-226 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50228-226 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50228-226. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.